To enhance melanoma immunotherapy, Li et al.78 combined the anti-programmed cell death 1 (PD-1) antibody with sialic acid (SA) -modified liposomes and loaded with chlorogenic acid (CA-SAL). This evidence concerns the gene PDCD1 and melanoma.